Autonomix Medical (AMIX) Income from Continuing Operations (2022 - 2025)
Autonomix Medical (AMIX) reported Income from Continuing Operations of 3261000.0 for Q4 2025, down 20.24% year-over-year from 4088687.93 in Q4 2024, and up 56.23% quarter-over-quarter from 7451000.0 in Q3 2025.
Autonomix Medical (AMIX) Income from Continuing Operations (2022 - 2025) Analysis & Trends
Autonomix Medical (AMIX) has 4 years of Income from Continuing Operations data on file, last reported at 3261000.0 in Q4 2025.
- Income from Continuing Operations for Q4 2025 came in at 3261000.0, down 20.24% year-over-year; the trailing twelve-month figure through Dec 2025 was 17240000.0 (down 26.52% YoY), and the FY2025 annual result was 11410000.0, up 26.03% from the prior year.
- Income from Continuing Operations rose to 3261000.0 in Q4 2025 per AMIX's latest filing, from 7451000.0 in the prior quarter.
- Over five years, Income from Continuing Operations peaked at 544000.0 in Q4 2022 and troughed at 7451000.0 in Q3 2025.
- A 4-year average of 3237307.69 and a median of 3113000.0 in 2023 frame the typical range for Income from Continuing Operations.
- On a YoY basis, Income from Continuing Operations climbed as much as 53.53% in 2024 and fell as far as 723.14% in 2024.
- A 4-year view of Income from Continuing Operations shows it stood at 544000.0 in 2022, then slumped by 472.24% to 3113000.0 in 2023, then climbed by 12.88% to 2712000.0 in 2024, then retreated by 20.24% to 3261000.0 in 2025.
- Business Quant data shows AMIX's Income from Continuing Operations at 3261000.0 in Q4 2025, 7451000.0 in Q3 2025, and 3337000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | 380.70 Mn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 411.00 Mn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 273.95 Mn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 199.50 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 220.30 Mn |
| 10 | Autonomix Medical | 3.33 Mn | 3.33 Mn | - | -3.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -3.26 Mn |
| Sep 30, 2025 | -7.45 Mn |
| Jun 30, 2025 | -3.34 Mn |
| Mar 31, 2025 | -3.19 Mn |
| Dec 31, 2024 | -2.71 Mn |
| Sep 30, 2024 | -2.81 Mn |
| Jun 30, 2024 | -2.70 Mn |
| Mar 31, 2024 | -5.41 Mn |
| Dec 31, 2023 | -3.11 Mn |
| Sep 30, 2023 | -6.04 Mn |
| Jun 30, 2023 | -865,000.00 |
| Mar 31, 2023 | -657,000.00 |
| Dec 31, 2022 | -544,000.00 |